首页> 外文期刊>World Journal of Gastroenterology >Microsatellite instable double primary cancers of the colorectum and stomach exhibit less favorable outcome
【24h】

Microsatellite instable double primary cancers of the colorectum and stomach exhibit less favorable outcome

机译:微卫星不稳定的结直肠癌和胃癌表现出较差的预后

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To ascertain the adequacy of the microsatellite instability (MSI) as a prognostic indicator by assessing MSI status of patients with double primary gastric and colorectal cancer (DPGCC). METHODS: Sixteen patients were studied, all of whom exhibited sporadic DPGCC, and had no family history of hereditary non-polyposis colorectal cancer, according to the Amsterdam criteria. A total of 32 cancers from 16 DPGCC patients, and 216 single primary CRC, were assessed for MSI in 5 microsatellite loci, BAT25, BAT26, D2S123, D5S346, and D17S250. RESULTS: MSI was observed in 6 (37.5%) of 16 GC and 4 (25.0%) of 16 CRC. Thirty tumors (13.9%) out of 216 single primary CRC and one tumor (16.7%) out of 6 double primary CRC were found to be microsatellite unstable. Of the 6 GC with MSI in DPGCC, 5 (31.3%) were MSI-high and one (6.3%) was MSI-low. In 5 of 16 DPGCC patients, the cancer recurred in or adjacent to the anastomosis or metastasized to the kidney or lung. The MSI-high DPGCC cases were associated with a younger age of onset (47.5 years vs62.5 years), higher frequency of lymph node metastasis (100% vs 25%), and advanced Dukes stage (C, 100% vs 41.7%), as well as a higher frequency of recurrence or metastasis (100% vs 8.3%). Only recurrence or metastasis showed statistical significance by Fisher's exact test. CONCLUSION: Our data suggest that MSI may play an important role in the development of DPGCC, and that it may be used clinically as a molecular predictive marker for recurrence or late metastasis of DPGCC.
机译:目的:通过评估患有双重原发性胃癌和结肠直肠癌(DPGCC)的患者的MSI状况,确定微卫星不稳定性(MSI)是否足以作为预后指标。方法:根据阿姆斯特丹的标准,对16例患者进行了研究,所有患者均散发DPGCC,并且没有遗传性非息肉性结直肠癌的家族史。来自5个微卫星基因座,BAT25,BAT26,D2S123,D5S346和D17S250的MSI评估了来自16位DPGCC患者的32种癌症和216个单原发CRC。结果:16例GC中有6例(37.5%)和16例CRC中有4例(25.0%)观察到MSI。发现216个单原发性CRC中有30个肿瘤(13.9%)和6个双原发性CRC中有1个肿瘤(16.7%)是微卫星不稳定的。在DPGCC中具有MSI的6个GC中,有5个(31.3%)是MSI高的,一个(6.3%)是MSI低的。在16例DPGCC患者中,有5例在吻合处或吻合处复发或转移至肾脏或肺部。 MSI高的DPGCC病例与较年轻的发病年龄(47.5岁vs 62.5岁),较高的淋巴结转移频率(100%vs 25%)和晚期Dukes分期(C,100%vs 41.7%)相关,以及更高的复发或转移频率(100%比8.3%)。通过Fisher精确检验,仅复发或转移显示统计学意义。结论:我们的数据表明MSI可能在DPGCC的发展中起重要作用,并且在临床上可作为DPGCC复发或晚期转移的分子预测标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号